2. L. bulgaricus GLB44 is one of 2000 known L
L. bulgaricus GLB44 is one of 2000 known L. bulgaricus strains with special bacteriocin producing characteristics
L. bulgaricus
L. Lactis
(4 cells)

3. Research Partnerships Across the Atlantic
Harvard Medical School
Sofia University Hospital
Brigham and Women’s Hospital
Sofia University

4. Inhibition of E. coli O104:H4

5. Inhibition of Salmonella typhimurium

6. Inhibition of Listeria monocytogenes

7. Summary of Inhibition Rates
% Inhibition using 1X
Inhibition Rate
Organism
Strain
Acinetobacter baumanii
ATCC 19606
>99
Enterococcus faecalis
ATCC 29200
ATCC 29212
Enterococcus faecium
ATCC 51559
>95
Esherichia coli
ATCC 25922
100
ATCC 35150
Listeria monocytogenes
ATCC BAA-751
Clinical Isolate
Psuedomonas aeruginosa
ATCC 27853
Salmonella typhimurium
Shigella sonnei
ATCC
Staphylococcus aureus
ATCC 12600
ATCC 25923
ATCC 29213
>98

11. FIRST VEGAN ORGANIC PROBIOTIC

13. Working together with Nobel Laureate Dr. Barry Marshall

14. Inhibition of H. pylori (in-vitro)

15. Dr. Barry Marshall becoming part of the human trial

16. The medical team working on the H. pylori trial at the
Sofia University Hospital

17. New H. pylori product launch:
750 mg slow release tablet